Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Massmann

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Personalized Medicine|May 9, 2024
Incidence of statin-associated muscle symptoms in patients taking statins with <i>RYR1</i> or <i>CACNA1S</i> variantsNatasha J Petry, Amanda Massmann, Megan Bell, et al.
Pharmacogenomics|May 1, 2023
Patient satisfaction with return of pharmacogenomic results utilizing a patient portal messageJoel Van Heukelom, Kristen Jacobsen, Natasha J Petry, et al.
Journal of Personalized Medicine|March 29, 2023
Metoprolol and <i>CYP2D6</i>: A Retrospective Cohort Study Evaluating Genotype-Based OutcomesSavannah Collett, Amanda Massmann, Natasha J Petry, et al.
Pharmacogenomics|March 21, 2025
Impact of a pharmacogenomics (PGx) clinic on patient satisfaction and PGx literacyAmanda Massmann, Jordan Baye, Max Weaver, et al.
The Pharmacogenomics Journal|May 21, 2026
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing populationJordan F Baye, Natasha J Petry, Lindsay Hines, et al.
Pharmacogenomics|July 1, 2022
Progression of precision statin prescribing for reduction of statin-associated muscle symptomsNatasha J Petry, Jordan F Baye, Samantha Frear, et al.
Frontiers in Pharmacology|November 30, 2023
Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare systemJoel Van Heukelom, Jennifer Morgan, Amanda Massmann, et al.
Pharmacogenomics|September 11, 2024
Evaluation of pharmacogenetic automated clinical decision support for clopidogrelAmanda Massmann, Joel Van Heukelom, Max Weaver, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 28, 2024
Implementation of CYP2C19 and CYP2D6 genotyping to guide antidepressant use in a large rural health systemNatasha J Petry, Joel Van Heukelom, April J Schultz, et al.
Pharmacogenomics|August 28, 2019
Implementation of wide-scale pharmacogenetic testing in primary careNatasha Petry, Jordan Baye, Aissa Aifaoui, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Personalized Medicine|May 9, 2024
Incidence of statin-associated muscle symptoms in patients taking statins with <i>RYR1</i> or <i>CACNA1S</i> variantsNatasha J Petry, Amanda Massmann, Megan Bell, et al.
Pharmacogenomics|May 1, 2023
Patient satisfaction with return of pharmacogenomic results utilizing a patient portal messageJoel Van Heukelom, Kristen Jacobsen, Natasha J Petry, et al.
Journal of Personalized Medicine|March 29, 2023
Metoprolol and <i>CYP2D6</i>: A Retrospective Cohort Study Evaluating Genotype-Based OutcomesSavannah Collett, Amanda Massmann, Natasha J Petry, et al.
Pharmacogenomics|March 21, 2025
Impact of a pharmacogenomics (PGx) clinic on patient satisfaction and PGx literacyAmanda Massmann, Jordan Baye, Max Weaver, et al.
The Pharmacogenomics Journal|May 21, 2026
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing populationJordan F Baye, Natasha J Petry, Lindsay Hines, et al.
Pharmacogenomics|July 1, 2022
Progression of precision statin prescribing for reduction of statin-associated muscle symptomsNatasha J Petry, Jordan F Baye, Samantha Frear, et al.
Frontiers in Pharmacology|November 30, 2023
Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare systemJoel Van Heukelom, Jennifer Morgan, Amanda Massmann, et al.
Pharmacogenomics|September 11, 2024
Evaluation of pharmacogenetic automated clinical decision support for clopidogrelAmanda Massmann, Joel Van Heukelom, Max Weaver, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 28, 2024
Implementation of CYP2C19 and CYP2D6 genotyping to guide antidepressant use in a large rural health systemNatasha J Petry, Joel Van Heukelom, April J Schultz, et al.
Pharmacogenomics|August 28, 2019
Implementation of wide-scale pharmacogenetic testing in primary careNatasha Petry, Jordan Baye, Aissa Aifaoui, et al.
Pageof 3